<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Genomics</journal-id><journal-id journal-id-type="iso-abbrev">BMC Genomics</journal-id><journal-title-group><journal-title>BMC Genomics</journal-title></journal-title-group><issn pub-type="epub">1471-2164</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5688477</article-id><article-id pub-id-type="publisher-id">4194</article-id><article-id pub-id-type="doi">10.1186/s12864-017-4194-4</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Epistasis, physical capacity-related genes and exceptional longevity: <italic>FNDC5</italic> gene interactions with candidate genes <italic>FOXOA3</italic> and <italic>APOE</italic></article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" equal-contrib="yes"><name><surname>Fuku</surname><given-names>Noriyuki</given-names></name><address><email>noriyuki.fuku@nifty.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>D&#x000ed;az-Pe&#x000f1;a</surname><given-names>Roberto</given-names></name><address><email>roberto.diaz@uautonoma.cl</email></address><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Arai</surname><given-names>Yasumichi</given-names></name><address><email>yasumich@keio.jp</email></address><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Abe</surname><given-names>Yukiko</given-names></name><address><email>yukiko_abe@hotmail.com</email></address><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Zempo</surname><given-names>Hirofumi</given-names></name><address><email>zempo.hirofumi@gmail.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Naito</surname><given-names>Hisashi</given-names></name><address><email>hnaitou@juntendo.ac.jp</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Murakami</surname><given-names>Haruka</given-names></name><address><email>haruka-m@nih.go.jp</email></address><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Miyachi</surname><given-names>Motohiko</given-names></name><address><email>miyachi@nih.go.jp</email></address><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Spuch</surname><given-names>Carlos</given-names></name><address><email>carlos.spuch@gmail.com</email></address><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><name><surname>Serra-Rexach</surname><given-names>Jos&#x000e9; A.</given-names></name><address><email>joseantonio.serra@salud.madrid.org</email></address><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name><surname>Emanuele</surname><given-names>Enzo</given-names></name><address><email>enzo.emanuele@2escience.com</email></address><xref ref-type="aff" rid="Aff7">7</xref></contrib><contrib contrib-type="author"><name><surname>Hirose</surname><given-names>Nobuyoshi</given-names></name><address><email>hirosen@z8.keio.jp</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Lucia</surname><given-names>Alejandro</given-names></name><address><email>alejandro.lucia@universidadeuropea.es</email></address><xref ref-type="aff" rid="Aff9">9</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1762 2738</institution-id><institution-id institution-id-type="GRID">grid.258269.2</institution-id><institution>Graduate School of Health and Sports Science, </institution><institution>Juntendo University, </institution></institution-wrap>Chiba, Japan </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 4904 3503</institution-id><institution-id institution-id-type="GRID">grid.420268.a</institution-id><institution>Hospital Universitari Institut Pere Mata, IISPV, URV. CIBERSAM, </institution></institution-wrap>Reus, Spain </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.441837.d</institution-id><institution>Facultad de Ciencias de la Salud, </institution><institution>Universidad Aut&#x000f3;noma de Chile, </institution></institution-wrap>Talca, Chile </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1936 9959</institution-id><institution-id institution-id-type="GRID">grid.26091.3c</institution-id><institution>Center for Supercentenarian Medical Research, </institution><institution>Keio University School of Medicine, </institution></institution-wrap>Tokyo, Japan </aff><aff id="Aff5"><label>5</label>Department of Physical Activity Research; National Institutes of Biomedical Innovation, Health and Nutrition, Tokyo, Japan </aff><aff id="Aff6"><label>6</label>Neurology Group, Galicia Sur Health Research Institute (IIS Galicia Sur), Centro de investigaci&#x000f3;n biom&#x000e9;dica en red del &#x000e1;rea de salud mental (CIBERSAM), Vigo, Spain </aff><aff id="Aff7"><label>7</label>2E Science, Robbio, (PV) Italy </aff><aff id="Aff8"><label>8</label>Centro de investigaci&#x000f3;n biom&#x000e9;dica en Envejecimiento y Fragilidad (CIBERFES), Madrid, Spain </aff><aff id="Aff9"><label>9</label>European University and Research Institute i+12, Madrid, Spain </aff></contrib-group><pub-date pub-type="epub"><day>14</day><month>11</month><year>2017</year></pub-date><pub-date pub-type="pmc-release"><day>14</day><month>11</month><year>2017</year></pub-date><pub-date pub-type="collection"><year>2017</year></pub-date><volume>18</volume><issue>Suppl 8</issue><issue-sponsor>Publication of this supplement has not been supported by sponsorship. Information about the source of funding for publication charges can be found in the individual articles. The articles have undergone the journal's standard peer review process for supplements. The Supplement Editors declare that they have no competing interests</issue-sponsor><elocation-id>803</elocation-id><permissions><copyright-statement>&#x000a9; The Author(s). 2017</copyright-statement><license license-type="OpenAccess"><license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><sec><title>Background</title><p id="Par1">Forkhead box O3A (<italic>FOXOA3)</italic> and apolipoprotein E (<italic>APOE</italic>) are arguably the strongest gene candidates to influence human exceptional longevity (EL, i.e., being a centenarian), but inconsistency exists among cohorts. Epistasis, defined as the effect of one locus being dependent on the presence of &#x02018;modifier genes&#x02019;, may contribute to explain the missing heritability of complex phenotypes such as EL. We assessed the potential association of epistasis among candidate polymorphisms related to physical capacity, as well as antioxidant defense and cardiometabolic traits, and EL in the Japanese population. A total of 1565 individuals were studied, subdivided into 822 middle-aged controls and 743 centenarians.</p></sec><sec><title>Results</title><p id="Par2">We found a <italic>FOXOA3</italic> rs2802292 T-allele-dependent association of fibronectin type III domain-containing 5 (<italic>FDNC5</italic>) rs16835198 with EL: the frequency of carriers of the <italic>FOXOA3</italic> rs2802292 T-allele among individuals with the rs16835198 GG genotype was significantly higher in cases than in controls (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05). On the other hand, among non-carriers of the <italic>APOE</italic> &#x02018;risk&#x02019; &#x003b5;4-allele, the frequency of the <italic>FDNC5</italic> rs16835198 G-allele was higher in cases than in controls (48.4% vs. 43.6%, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05). Among carriers of the &#x02018;non-risk&#x02019; <italic>APOE</italic> &#x003b5;2-allele, the frequency of the rs16835198 G-allele was higher in cases than in controls (49% vs. 37.3%, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05).</p></sec><sec><title>Conclusions</title><p id="Par3">The association of <italic>FDNC5</italic> rs16835198 with EL seems to depend on the presence of the <italic>FOXOA3</italic> rs2802292 T-allele and we report a novel association between <italic>FNDC5</italic> rs16835198 stratified by the presence of the <italic>APOE</italic> &#x003b5;2/&#x003b5;4-allele and EL. More research on &#x02018;gene*gene&#x02019; and &#x02018;gene*environment&#x02019; effects is needed in the field of EL.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Exceptional longevity</kwd><kwd>Centenarians</kwd><kwd>FOXO3A</kwd><kwd>FNDC5</kwd><kwd>APOE</kwd><kwd>Ageing</kwd></kwd-group><conference xlink:href="http://www.fims2016.org/en/"><conf-name>34th FIMS World Sports Medicine Congress</conf-name><conf-acronym>Genetics, Genomics and Exercise Biology</conf-acronym><conf-loc>Ljubljana, Slovenia</conf-loc><conf-date>29/09/16-02/10/16</conf-date></conference><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2017</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p id="Par26">Exceptional longevity (EL), defined as reaching 100+ years of age, is a generally accepted model of healthy aging with major age-related diseases usually delayed [<xref ref-type="bibr" rid="CR1">1</xref>], and sometimes even avoided, in centenarians [<xref ref-type="bibr" rid="CR2">2</xref>]. Age at death during adulthood has a heritability of ~&#x02009;25% [<xref ref-type="bibr" rid="CR3">3</xref>] and consequently EL is likely to be, at least in part, a heritable phenotype. However, genome wide association studies (GWAS) of individuals with EL have mostly yielded poor results, with single nucleotide polymorphisms (SNPs) in the apolipoprotein E (<italic>APOE</italic>) and/or forkhead box O3A (<italic>FOXOA3</italic>) genes being usually the only variants achieving genome-wide significance [<xref ref-type="bibr" rid="CR3">3</xref>], although there is no unanimity for <italic>FOXOA3</italic> [<xref ref-type="bibr" rid="CR4">4</xref>]. The <italic>APOE</italic> &#x003b5;4-allele, which is linked to a higher risk of cardiovascular and Alzheimer&#x02019;s disease [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>], is associated with a lower likelihood of reaching EL, whereas the &#x003b5;2-allele seems to show a positive association with EL and is more frequently found in centenarians than in younger controls [<xref ref-type="bibr" rid="CR7">7</xref>]. Nonetheless, the aforementioned associations can vary by population [<xref ref-type="bibr" rid="CR7">7</xref>]. Similarly, there is evidence that genetic polymorphisms in the <italic>FOXO3A</italic> gene can be associated with EL, especially the rs2802292 SNP [<xref ref-type="bibr" rid="CR8">8</xref>&#x02013;<xref ref-type="bibr" rid="CR12">12</xref>], but such an association has not been corroborated in some cohorts [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR14">14</xref>]. On the other hand, aging is inevitably associated with a decline physical function, especially in muscle mass and function (i.e., sarcopenia), with an acceleration of this process increasing the risk of mortality [<xref ref-type="bibr" rid="CR15">15</xref>]. As such, there is a rationale for postulating the potential influence on EL of several variations in genes that are candidates to influence physical capacity and muscle function; however, up to date such candidate genes [e.g., &#x003b1;-actinin-3 (<italic>ACTN3</italic>), thyrotropin-releasing hormone (<italic>TRHR</italic>) or acyl-CoA synthetase long-chain family member 1 (<italic>ACSL1</italic>)], have not shown individual associations with EL [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR17">17</xref>].</p><p id="Par27">Epistasis, defined as the effect of one locus on a given phenotype being dependent on the presence of one or more &#x02018;modifier genes&#x02019;, may contribute to explain the missing heritability of complex phenotypes [<xref ref-type="bibr" rid="CR18">18</xref>]. Though research on the role of epistasis in EL has been rather limited in the past [<xref ref-type="bibr" rid="CR19">19</xref>], evidence for an impact of genetic interactions in determining human longevity is quickly growing. For instance, longevity may be partly determined by epistatic interactions involving mitochondrial DNA (mtDNA) loci [<xref ref-type="bibr" rid="CR20">20</xref>]. Also, a combination of functional SNPs within adenosine deaminase (<italic>ADA</italic>) and tumor necrosis factor alpha (<italic>TNF-&#x003b1;</italic>) genes can influence life-expectancy in a gender-specific manner [<xref ref-type="bibr" rid="CR21">21</xref>]. More recently, Tan et al. reported that interactions of SNPs in the <italic>FOXO</italic> gene family influences longevity [<xref ref-type="bibr" rid="CR22">22</xref>]. To our knowledge, only two studies have included the <italic>APOE</italic> gene for evaluating gene x gene effects on longevity [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR24">24</xref>]. Jazwinski et al. reported that the GTPase HRAS (also known as transforming protein p21, <italic>HRAS1</italic>) and ceramide synthase 1 (also known as LAG1, longevity assurance homolog, <italic>LASS1</italic>) genes interact with the <italic>APOE</italic> gene to reduce age-related increases in lipotoxic events, and haplotypes conformed by the two genes are associated with EL [<xref ref-type="bibr" rid="CR23">23</xref>]. In the other study, epistasis analysis was performed between <italic>APOE</italic> haplotypes and haptoglobulin gene (<italic>HP</italic>) functional polymorphisms, with <italic>HP</italic> *1/*1 genotype protecting <italic>APOE</italic> &#x003b5;4-carriers from age-related negative selection; in light of these results, the authors called for further research on <italic>APOE/HP</italic> interactions in age-related diseases such as Alzheimer&#x02019;s and Parkinson&#x02019;s disease [<xref ref-type="bibr" rid="CR24">24</xref>].</p><p id="Par28">Japan has the longest life expectancy in the world, as well as the highest number of individuals reaching EL [<xref ref-type="bibr" rid="CR25">25</xref>]. Thus, Japanese long-lived people represent an attractive model to study potential genetic contributors to EL. The purpose of the present study was to assess whether the interaction between variants in genes that are candidates to influence physical capacity and energy metabolism [<italic>ACTN3</italic>, <italic>TRHR</italic>, <italic>ACSL1</italic>], interact with <italic>APOE</italic> and <italic>FOXO3A</italic> genes, and potentially associate with EL in the Japanese population. We also studied the potential interaction with candidate genes involved in antioxidant defense [glutathione peroxidase 1 (<italic>GPX1</italic>), superoxide dismutase 2 (<italic>SOD2</italic>)] and cardiometabolic traits [fibronectin type III domain-containing 5 (<italic>FNDC5</italic>), cyclin-dependent kinase inhibitor 2B antisense noncoding RNA (<italic>CDKN2B-AS1</italic>)],</p></sec><sec id="Sec2"><title>Results</title><p id="Par29">The observed genotypic distributions of SNPs were consistent with Hardy&#x02013;Weinberg Equilibrium (HWE) expectations both in controls and centenarians (<italic>P</italic>&#x02009;&#x0003e;&#x02009;0.05). Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref> shows the single marker allelic association results of the 12 SNPs included in the study. The frequency of the <italic>APOE</italic> &#x003b5;2-allele was higher in cases than in controls, whereas &#x003b5;4-allele frequency was lower in the former (all <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.01), as shown previously by us using part of the present cohort [<xref ref-type="bibr" rid="CR26">26</xref>]. None of the other SNPs, including <italic>FOXOA3</italic> rs2802292, was associated with EL, and genotypes did not differ significantly between cases and controls in the recessive, dominant or additive models (all <italic>P</italic>&#x02009;&#x0003e;&#x02009;0.05) (data not shown). No significant differences were observed in sex-based analyses (data not shown).<table-wrap id="Tab1"><label>Table 1</label><caption><p>Single marker allelic association results of the 12 genetic variants included in the study</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Chromosome</th><th>SNP</th><th>Gene</th><th>Position</th><th>Minor allele<break/>nucleotide</th><th colspan="2">Minor allele frequency</th><th>P<sub>BONF</sub>
</th><th>OR</th><th>lower 95%CI</th><th>Upper 95%CI</th></tr><tr><th/><th/><th/><th/><th/><th>Centenarians</th><th>Controls</th><th/><th/><th/><th/></tr></thead><tbody><tr><td>1</td><td>rs16835198</td><td>
<italic>FNDC5</italic>
</td><td>32,861,080</td><td>G</td><td>0.48</td><td>0.45</td><td>0.488</td><td>1.16</td><td>1.00</td><td>1.33</td></tr><tr><td>2</td><td>rs1050450</td><td>
<italic>GPX1</italic>
</td><td>49,357,401</td><td>T</td><td>0.08</td><td>0.08</td><td>1</td><td>0.95</td><td>0.73</td><td>1.25</td></tr><tr><td>4</td><td>rs6552828</td><td>
<italic>ASCL1</italic>
</td><td>1.85E&#x000a0;+&#x000a0;08</td><td>G</td><td>0.40</td><td>0.41</td><td>1</td><td>0.95</td><td>0.82</td><td>1.10</td></tr><tr><td>6</td><td>rs4880</td><td>
<italic>SOD2</italic>
</td><td>1.6E&#x000a0;+&#x000a0;08</td><td>G</td><td>0.13</td><td>0.14</td><td>1</td><td>0.94</td><td>0.77</td><td>1.16</td></tr><tr><td>8</td><td>rs7832552</td><td>
<italic>TRHR</italic>
</td><td>1.09E&#x000a0;+&#x000a0;08</td><td>T</td><td>0.50</td><td>0.50</td><td>1</td><td>0.97</td><td>0.85</td><td>1.12</td></tr><tr><td>8</td><td>rs7460</td><td>
<italic>PTK2</italic>
</td><td>1.41E&#x000a0;+&#x000a0;08</td><td>T</td><td>0.36</td><td>0.36</td><td>1</td><td>1.00</td><td>0.860</td><td>1.15</td></tr><tr><td>8</td><td>rs7843014</td><td>
<italic>PTK2</italic>
</td><td>1.41E&#x000a0;+&#x000a0;08</td><td>A</td><td>0.25</td><td>0.27</td><td>1</td><td>0.88</td><td>0.75</td><td>1.04</td></tr><tr><td>9</td><td>rs1333049</td><td>
<italic>CDKN2B-AS1</italic>
</td><td>22,125,504</td><td>C</td><td>0.47</td><td>0.46</td><td>1</td><td>1.05</td><td>0.91</td><td>1.21</td></tr><tr><td>9</td><td>rs2802292</td><td>
<italic>FOXO3A</italic>
</td><td>108,587,315</td><td>G</td><td>0.29</td><td>0.28</td><td>1</td><td>1.05</td><td>0.90</td><td>1.23</td></tr><tr><td>11</td><td>rs1815739</td><td>
<italic>ACTN3</italic>
</td><td>66,560,624</td><td>C</td><td>0.46</td><td>0.47</td><td>1</td><td>0.96</td><td>0.84</td><td>1.11</td></tr><tr><td>19</td><td>rs429358</td><td>
<italic>APOE</italic>
</td><td>44,908,684</td><td>C</td><td>0.05</td><td>0.11</td><td>6.19&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;10</sup>
</td><td>0.39</td><td>0.29</td><td>0.52</td></tr><tr><td>19</td><td>rs7412</td><td>
<italic>APOE</italic>
</td><td>44,908,882</td><td>T</td><td>0.07</td><td>0.04</td><td>0.002</td><td>1.80</td><td>1.32</td><td>2.46</td></tr></tbody></table><table-wrap-foot><p>Allele frequencies were compared using chi-square statistics; ORs and 95% confidence interval (95% CI) were calculated using Plink software</p><p>
<italic>Abbreviations</italic>: <italic>95%CI</italic> 95% confidence interval, <italic>OR</italic> odds ratio, <italic>P</italic>
<sub><italic>BONF</italic></sub>
<italic>P</italic>-value after Bonferroni correction, <italic>SNP</italic> single nucleotide polymorphism</p></table-wrap-foot></table-wrap>
</p><p id="Par30">With regards to epistasis, we found a <italic>FOXOA3</italic> rs2802292 T-allele-dependent association of fibronectin type III domain-containing 5 (<italic>FDNC5</italic>) rs16835198 with EL, that is, among individuals with the rs16835198 GG genotype, the frequency of carriers of the <italic>FOXOA3</italic> rs2802292 T-allele was significantly higher in cases than in controls (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05; Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>). On the other hand, among non-carriers of the <italic>APOE</italic> &#x02018;risk&#x02019; &#x003b5;4-allele, the frequency of the <italic>FDNC5</italic> rs16835198 G-allele was higher in cases than in controls (48.4% vs. 43.6%, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05; Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>). In turn, among carriers of the &#x02018;non-risk&#x02019; <italic>APOE</italic> &#x003b5;2-allele, the frequency of the rs16835198 G-allele was higher in cases than in controls (49% vs. 37.3%, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05). No other significant gene interaction was found to be associated with EL.<table-wrap id="Tab2"><label>Table 2</label><caption><p>Genotypic frequency distribution of <italic>FNDC5</italic> rs16835198 according to the <italic>FDNC5</italic> rs16835198 T-allele presence</p></caption><table frame="hsides" rules="groups"><thead><tr><th>
<italic>FDNC5</italic> (rs16835198)<break/>Genotype</th><th colspan="2">
<italic>FOXO3A</italic> Presence of rs2802292 T-allele</th><th>
<italic>P</italic>-value</th><th>OR (95% CI)</th></tr><tr><th/><th>Controls (<italic>n</italic>&#x02009;=&#x02009;754)</th><th>Centenarians (<italic>n</italic>&#x02009;=&#x02009;668)</th><th/><th/></tr></thead><tbody><tr><td>GG</td><td>147 (19.5%)</td><td>162 (24.3%)</td><td>0.035</td><td>1.32 (1.03&#x02013;1.70)</td></tr><tr><td>GT</td><td>378 (50.1%)</td><td>323 (48.3%)</td><td>NS</td><td>&#x02013;</td></tr><tr><td>TT</td><td>229 (30.4%)</td><td>183 (27.4%)</td><td>NS</td><td>&#x02013;</td></tr></tbody></table><table-wrap-foot><p>
<italic>Abbreviations</italic>: <italic>95%CI</italic> 95% confidence interval, <italic>NS</italic> not significant, <italic>OR</italic> odds ratio</p></table-wrap-foot></table-wrap>
<table-wrap id="Tab3"><label>Table 3</label><caption><p>Allele frequency distribution of <italic>FNDC5</italic> rs16835198 alleles according to <italic>APOE</italic> &#x003b5;2/&#x003b5;4 status in the study population</p></caption><table frame="hsides" rules="groups"><tbody><tr><td>
<italic>FNDC5</italic> (rs16835198)allele</td><td/><td colspan="2">Absence of <italic>APOE</italic> &#x003b5;4-allele<sup>a</sup>
</td><td colspan="2">
<italic>Presence of APOE</italic> &#x003b5;4-allele<sup>a</sup>
</td></tr><tr><td/><td/><td>Controls (2n&#x02009;=&#x02009;1306)</td><td>Centenarians (2n&#x02009;=&#x02009;1340)</td><td>Controls (2n&#x02009;=&#x02009;336)</td><td>Centenarians (2n&#x02009;=&#x02009;128)</td></tr><tr><td rowspan="4">G</td><td>N</td><td>570</td><td>648</td><td>165</td><td>62</td></tr><tr><td>%</td><td>43.6%</td><td>48.4%</td><td>49.1%</td><td>48.4%</td></tr><tr><td>
<italic>P</italic>-value</td><td colspan="2">0.0167</td><td colspan="2">NS</td></tr><tr><td>OR (95% CI)</td><td colspan="2">1.21 (1.04, 1.41)</td><td colspan="2">&#x02013;</td></tr><tr><td rowspan="4">T</td><td>N</td><td>736</td><td>692</td><td>171</td><td>66</td></tr><tr><td>%</td><td>56.4%</td><td>51.6%</td><td>50.9%</td><td>51.6%</td></tr><tr><td>
<italic>P</italic>-value</td><td colspan="2">0.0167</td><td colspan="2">NS</td></tr><tr><td>OR (95% CI)</td><td colspan="2">0.83 (0.71&#x02013;0.96)</td><td colspan="2">&#x02013;</td></tr><tr><td>
<italic>FNDC5</italic> (rs16835198)allele</td><td/><td colspan="2">Absence of <italic>APOE</italic> &#x003b5;2-allele<sup>a</sup>
</td><td colspan="2">Presence of <italic>APOE</italic> &#x003b5;2-allele<sup>a</sup>
</td></tr><tr><td/><td/><td>Controls (2n&#x02009;=&#x02009;1508)</td><td>Centenarians (2n&#x02009;=&#x02009;1258)</td><td>Controls (2n&#x02009;=&#x02009;134)</td><td>Centenarians (2n&#x02009;=&#x02009;210)</td></tr><tr><td rowspan="4">G</td><td>n</td><td>685</td><td>607</td><td>50</td><td>103</td></tr><tr><td>%</td><td>45.4%</td><td>48.3%</td><td>37.3%</td><td>49%</td></tr><tr><td>
<italic>P</italic>-value</td><td colspan="2">NS</td><td colspan="2">0.035</td></tr><tr><td>OR (95% CI)</td><td colspan="2">&#x02013;</td><td colspan="2">1.62 (1.04&#x02013;2.52)</td></tr><tr><td rowspan="4">T</td><td>n</td><td>823</td><td>651</td><td>84</td><td>107</td></tr><tr><td>%</td><td>54.6%</td><td>51.7%</td><td>62.7%</td><td>51%</td></tr><tr><td>
<italic>P</italic>-value</td><td colspan="2">NS</td><td colspan="2">0.035</td></tr><tr><td>OR (95% CI)</td><td colspan="2">&#x02013;</td><td colspan="2">0.62 (0.40&#x02013;0.96)</td></tr></tbody></table><table-wrap-foot><p>
<italic>Abbreviations</italic>: <italic>95%CI</italic> 95% confidence interval, <italic>NS</italic> not significant, <italic>OR</italic> odds ratio</p><p>
<sup>a</sup>All individuals underwent genotyping for rs429358 and rs7412. The 3 major isoforms of human APOE gene (E2, E3, and E4) coded by 3 alleles (&#x003b5;2, &#x003b5;3, and &#x003b5;4) differ in amino acid sequence at 2 sites, residue 112 (rs429358) and residue 158 (rs7412)</p></table-wrap-foot></table-wrap>
</p></sec><sec id="Sec3"><title>Discussion</title><p id="Par31">Excluding <italic>APOE</italic>, the present findings do not show replicable association of individual candidate genes, included those related to physical capacity and muscle function, with EL. However, we also assessed the effects of interactions among candidate polymorphisms on the one hand, and EL, on the other hand. In this regard, we report an association of <italic>FDNC5</italic> rs16835198 with EL that seems to depend on the presence of the <italic>FOXOA3</italic> rs2802292 T-allele. Moreover, we found a novel association between <italic>FNDC5</italic> rs16835198 stratified by the presence of the <italic>APOE</italic> &#x003b5;2/&#x003b5;4-allele, and EL. We believe this is an interesting finding because <italic>FNDC5</italic> gene encodes the precursor of irisin which, although there is controversy [<xref ref-type="bibr" rid="CR27">27</xref>], was recently identified a myokine -that is, a molecule released by muscles [<xref ref-type="bibr" rid="CR28">28</xref>]. Irisin induces expression of uncoupling protein 1 and other brown adipose tissue-associated genes [partly via increased peroxisome proliferators-activated receptor &#x003b1; (PPAR-&#x003b1;)] in white adipocytes, and thus increases thermogenesis and switching of these cells towards a brown fat-like phenotype [<xref ref-type="bibr" rid="CR28">28</xref>]. In fact irisin has been postulated as a therapeutic agent against cardiometabolic disorders and a major component of the &#x02018;exercise polypill&#x02019; [<xref ref-type="bibr" rid="CR29">29</xref>].</p><p id="Par32">Several mechanisms may link genetic variations in <italic>FOXO3A</italic> and <italic>FNDC5</italic> genes with EL. For example, dysregulation of the nutrient-sensing somatotropic axis [comprising growth hormone and its secondary mediator, insulin-like growth factor-1 (IGF-1)] is a major hallmark of human aging [<xref ref-type="bibr" rid="CR30">30</xref>]. IGF-1 and insulin signaling collectively represent the &#x0201c;insulin and IGF-1 signaling&#x0201d; pathway. Among the multiple targets of this pathway is the FOXO family of transcription factors, which are also involved in aging and show striking evolutionary conservation [<xref ref-type="bibr" rid="CR31">31</xref>]. High serum irisin levels may contribute to successful aging, with circulating levels of this biomarker being in fact significantly higher in disease-free centenarians than in young healthy controls and being particularly higher than in young patients with acute myocardial infarction [<xref ref-type="bibr" rid="CR32">32</xref>]. Moreover, genetic variants in the <italic>FNDC5</italic> gene have been associated with in vivo insulin sensitivity [<xref ref-type="bibr" rid="CR33">33</xref>], and aging is associated with alterations in insulin sensitivity/signaling [<xref ref-type="bibr" rid="CR34">34</xref>]. Irisin might also play a significant role in reducing the risk of obesity or several related diseases [<xref ref-type="bibr" rid="CR35">35</xref>]. In a previous report, we found no significant association between genotype and allele frequencies of polymorphisms in <italic>FNDC5</italic> and EL [<xref ref-type="bibr" rid="CR36">36</xref>]. However, the rs16835198 G-allele was associated with a trend towards lower luciferase gene repoter activity in vitro [<xref ref-type="bibr" rid="CR36">36</xref>].</p><p id="Par33">Insulin sensitivity could be a link explaining the association of the combination of the two loci in <italic>FOXO3A</italic> and <italic>FNDC5,</italic> as well as in <italic>APOE</italic> and <italic>FNDC5</italic>, with EL. Insulin metabolism as well as insulin-altering therapies in Alzheimer&#x02019;s disease are modulated by <italic>APOE</italic> status [<xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR38">38</xref>], while irisin reduces diet-induced obesity and insulin resistance in vivo [<xref ref-type="bibr" rid="CR28">28</xref>]. The <italic>FNDC5</italic> rs16835198 G-allele could favor longevity in combination with the <italic>APOE</italic> &#x003b5;2-variant, contributing to situations in which rs16835198 SNP distribution is found among long-lived subjects in proportions similar to those found in younger controls. Thus, the conditional effects of genes on the phenotype of aging could play a role in longevity. Most studies show a lower frequency of the <italic>APOE</italic> &#x003b5;4-allele in centenarians than in younger controls, while the <italic>APOE</italic> &#x003b5;2-allele might be more frequent in centenarians than in younger controls [<xref ref-type="bibr" rid="CR7">7</xref>]. A &#x0201c;gene x gene&#x0201d; interaction would introduce a modifying allele in another locus, changing the impact of the risk/protective allele from deleterious to beneficial, or vice versa. Here, we report a significant effect of the rs16835198-G allele in the <italic>FNDC5</italic> gene on the association between <italic>APOE</italic> &#x003b5;2 carriage/non-carriage and EL. There are some limitations in our study. First, our results should be ideally replicated in one or more ethnically and geographically-independent cohorts to account for potential differences in &#x02018;gene x environment&#x02019; interactions. Another drawback of case: control designs as the present one is the choice of an appropriate control group, with demographic factors, notably differences in year of birth between centenarians and controls, being potential confounders (e.g., the centenarians and controls of our study were born in the early 1900s and after 1930, respectively) [<xref ref-type="bibr" rid="CR39">39</xref>]. Differences in gender distribution between cases and controls are also to be accounted for because genetic factors influence survival at advanced age in a sex-specific manner [<xref ref-type="bibr" rid="CR40">40</xref>]. In this regard, the potential demographic biases of cross-sectional comparisons of genotype/allele frequencies between controls and long lived individuals could be overcome by adding more complete demographic information to genetic data, allowing for estimation of survival rates related to candidate genes [<xref ref-type="bibr" rid="CR40">40</xref>&#x02013;<xref ref-type="bibr" rid="CR42">42</xref>]. Because we have only analyzed one SNP within the <italic>FOXO3A</italic> and <italic>FNDC5</italic> genes, further research with different variants of this or other genes involved in insulin-IGF-1, and insulin signaling collectively representing the &#x0201c;insulin and IGF-1 signaling&#x0201d; pathway, must be undertaken. On the other hand, the need for using independent populations for replication may generate some controversy. Some variants may have opposing consequences on the phenotype of interest, and the effect of gene x gene interactions on human health and lifespan might depend on several factors (e.g., internal and external exposure, including medication or different genetic backgrounds of individuals comprising the populations).</p></sec><sec id="Sec4"><title>Conclusion</title><p id="Par34">We found an association between <italic>FDNC5</italic> rs16835198 stratified by the presence of the <italic>FOXOA3</italic> rs2802292 T-allele, and EL, as well as between <italic>FNDC5</italic> rs16835198 stratified by the presence of the <italic>APOE</italic> alleles, and EL. Our results suggest the need for further investigation on the possible influence of <italic>FOXO3A/FNDC5</italic> interactions and <italic>APOE/FNDC5</italic> interactions with EL, but also with other age-related diseases such as atherosclerosis, Alzheimer&#x02019;s, or Parkinson&#x02019;s disease. Moreover, identification of gene x gene and gene x environmental factors effects on lifespan may significantly improve our understanding of the association between genetic and non-genetic regulators of aging.</p></sec><sec id="Sec5"><title>Methods</title><sec id="Sec6"><title>Study population</title><p id="Par35">A total of 1565 individuals were recruited: 822 controls (aged 23&#x02013;65&#x000a0;years; 604 women, 218 men) and 743 cases (centenarians aged 100&#x02013;115&#x000a0;years; 623 women, 1120 men). The controls were enrolled from the Nutrition and EXercise Intervention Study (NEXIS) registered on <ext-link ext-link-type="uri" xlink:href="http://clinicaltrials.gov">ClinicalTrials.gov</ext-link> (Identifier: NCT 00926744). Inclusion criteria for the control group were being a man or woman aged 23&#x02013;65&#x000a0;years with no history of stroke, cardiovascular disease, chronic renal failure, or walking difficulties related to knee or back pain [<xref ref-type="bibr" rid="CR43">43</xref>]. Cases were collected from two cohorts that have been described in detail elsewhere [<xref ref-type="bibr" rid="CR44">44</xref>]: the Tokyo Centenarians Study (TCS) and the Semi-Supercentenarians Study in Japan (SSC-J). The prevalence rates of hypertension, coronary artery disease and dementia in the Japanese centenarians were 63.6, 28.8 and 59.4%, respectively [<xref ref-type="bibr" rid="CR26">26</xref>].</p></sec><sec id="Sec7"><title>Genotyping</title><p id="Par36">Total DNA was extracted from venous blood with the QIAamp DNA Blood Maxi Kit (Qiagen, Hilden, Germany). SNP genotyping was performed using the following TaqMan&#x000ae; genotyping assays (Applied Biosystems, Foster City, CA): C__34204885_10 for rs16835198, Custom TaMan&#x000ae; Assay for rs1050450, C__30469648_10 for rs6552828, C___8709053_10 for rs4880, C__29085798_10 for rs7832552, C____243385_10 for rs7460, C__11605645_10 for rs7843014, C___1754666_10 for rs1333049, C___1841568_10 for rs2802292, C____590093_1 for rs1815739, C____904973_10 for rs7412 and C___3084793_20 for rs429358. Several quality control procedures, such as repeating the genotyping on a random 10% of the samples were carried out to assure no discrepant results in samples.</p></sec><sec id="Sec8"><title>Statistical analysis</title><p id="Par37">Statistical analysis of high-density SNP genotyping data was carried out as follows: allele frequencies in cases and controls were compared using chi-square statistics, and odds ratios (OR) and 95% confidence intervals (95% CI) were calculated using Plink software [<xref ref-type="bibr" rid="CR45">45</xref>]. Bonferroni correction was applied by dividing the <italic>P-</italic>value by the number of SNPs tested to give the corrected <italic>P-</italic>value. Allele frequencies obtained for each SNP were tested for deviations from HWE expectations. The combined effects of <italic>APOE</italic> and <italic>FOXO3A</italic> alleles and SNPs studied on the risk of EL were analyzed by binary logistic regression with SPSS v.22 statistical software (IBM, Somers, NY, USA) and OR and <italic>P</italic> values were calculated.</p></sec></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>ACSL1</term><def><p id="Par4">Acyl-CoA synthetase long-chain family member 1</p></def></def-item><def-item><term>ACTN3</term><def><p id="Par5">Actinin-3</p></def></def-item><def-item><term>ADA</term><def><p id="Par6">Adenosine deaminase</p></def></def-item><def-item><term>APOE</term><def><p id="Par7">Apolipoprotein E</p></def></def-item><def-item><term>CDKN2B-AS1</term><def><p id="Par8">Cyclin-dependent kinase inhibitor 2B antisense noncoding RNA</p></def></def-item><def-item><term>EL</term><def><p id="Par9">Exceptional longevity</p></def></def-item><def-item><term>FNDC5</term><def><p id="Par10">Fibronectin type III domain-containing 5</p></def></def-item><def-item><term>FOXOA3</term><def><p id="Par11">Forkhead box O3A</p></def></def-item><def-item><term>GPX1</term><def><p id="Par12">Glutathione peroxidase 1</p></def></def-item><def-item><term>GWAS</term><def><p id="Par13">Genome wide association studies</p></def></def-item><def-item><term>HP</term><def><p id="Par14">Haptoglobulin gene</p></def></def-item><def-item><term>HWE</term><def><p id="Par15">Hardy&#x02013;Weinberg Equilibrium</p></def></def-item><def-item><term>IGF-1</term><def><p id="Par16">Insulin-like growth factor-1</p></def></def-item><def-item><term>mtDNA</term><def><p id="Par17">Mitochondrial DNA</p></def></def-item><def-item><term>NEXIS</term><def><p id="Par18">Nutrition and EXercise Intervention Study</p></def></def-item><def-item><term>OR</term><def><p id="Par19">Odds ratios</p></def></def-item><def-item><term>SNPs</term><def><p id="Par20">Single nucleotide polymorphisms</p></def></def-item><def-item><term>SOD2</term><def><p id="Par21">Superoxide dismutase 2</p></def></def-item><def-item><term>SSC-J</term><def><p id="Par22">Semi-Supercentenarians Study in Japan</p></def></def-item><def-item><term>TCS</term><def><p id="Par23">Tokyo Centenarians Study</p></def></def-item><def-item><term>TNF-&#x003b1;</term><def><p id="Par24">Tumor necrosis factor alpha</p></def></def-item><def-item><term>TRHR</term><def><p id="Par25">Thyrotropin-releasing hormone</p></def></def-item></def-list></glossary><ack><title>Acknowledgements</title><p>The authors acknowledge Dr. Kenneth McCreath for his editorial work.</p><sec id="FPar1"><title>Funding</title><p id="Par38">Publication of this article is supported by grants from the Grant-in-Aid for Scientific Research (B) (15H03081 to N.F.) and Challenging Exploratory Research (16&#x000a0;K13052 to N.F.) programs of the Ministry of Education, Culture, Sports, Science and by a Grant-in-Aid for Scientific Research from the Ministry of Health, Labor, and Welfare of Japan (to M. M). Research by <italic>A. Lucia</italic> is supported by grants from the Spanish Ministry of Economy and Competitiveness and [<italic>Fondo de Investigaciones Sanitarias</italic> (FIS)] and <italic>Fondos Feder</italic> (grant number PI15/00558).</p></sec><sec id="FPar2"><title>Availability of data and materials</title><p id="Par39">All data generated and/or analyzed during this study are included in this published article.</p></sec><sec id="FPar3"><title>About this supplement</title><p id="Par40">This article has been published as part of <italic>BMC Genomics</italic> Volume 18 Supplement 8, 2017: Proceedings of the 34th FIMS World Sports Medicine Congress. The full contents of the supplement are available online at <ext-link ext-link-type="uri" xlink:href="https://bmcgenomics.biomedcentral.com/articles/supplements/volume-18-supplement-8">https://bmcgenomics.biomedcentral.com/articles/supplements/volume-18-supplement-8</ext-link>.</p></sec></ack><notes notes-type="author-contribution"><title>Authors&#x02019; contributions</title><p>All authors were involved in drafting the article or revising it critically for important intellectual content, and all authors approved the final version to be published. Study conception and design. DPR, FN and LA. Acquisition of data. Arai Y, Abe Y, ZH, Naito H, MH, MM and Hirose N. Analysis and interpretation of data. DPR, SRJA, SC and EE.</p></notes><notes notes-type="COI-statement"><sec id="FPar4"><title>Ethics approval and consent to participate</title><p id="Par41">The Ethics Committees of the Keio University and National Institute of Health and Nutrition approved this study and all subjects gave their written informed consent.</p></sec><sec id="FPar5"><title>Consent for publication</title><p id="Par42">Not applicable.</p></sec><sec id="FPar6"><title>Competing interests</title><p id="Par43">The authors declare that they have no competing interests.</p></sec><sec id="FPar7"><title>Publisher&#x02019;s Note</title><p id="Par44">Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></sec></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soerensen</surname><given-names>M</given-names></name><name><surname>Nygaard</surname><given-names>M</given-names></name><name><surname>Debrabant</surname><given-names>B</given-names></name><name><surname>Mengel-From</surname><given-names>J</given-names></name><name><surname>Dato</surname><given-names>S</given-names></name><name><surname>Thinggaard</surname><given-names>M</given-names></name><etal/></person-group><article-title>No association between variation in longevity candidate genes and aging-related phenotypes in oldest-old Danes</article-title><source>Exp Gerontol</source><year>2016</year><volume>78</volume><fpage>57</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1016/j.exger.2016.03.001</pub-id><?supplied-pmid 26946122?><pub-id pub-id-type="pmid">26946122</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Terry</surname><given-names>DF</given-names></name><name><surname>Sebastiani</surname><given-names>P</given-names></name><name><surname>Andersen</surname><given-names>SL</given-names></name><name><surname>Perls</surname><given-names>TT</given-names></name></person-group><article-title>Disentangling the roles of disability and morbidity in survival to exceptional old age</article-title><source>Arch Intern Med</source><year>2008</year><volume>168</volume><fpage>277</fpage><lpage>283</lpage><pub-id pub-id-type="doi">10.1001/archinternmed.2007.75</pub-id><?supplied-pmid 18268168?><pub-id pub-id-type="pmid">18268168</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brooks-Wilson</surname><given-names>AR</given-names></name></person-group><article-title>Genetics of healthy aging and longevity</article-title><source>Hum Genet</source><year>2013</year><volume>132</volume><fpage>1323</fpage><lpage>1338</lpage><pub-id pub-id-type="doi">10.1007/s00439-013-1342-z</pub-id><?supplied-pmid 23925498?><pub-id pub-id-type="pmid">23925498</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><mixed-citation publication-type="other">Sebastiani P, Gurinovich A, Bae H, Andersen S, Malovini A, Atzmon G, et al. Four Genome-Wide Association Studies Identify New Extreme Longevity Variants. J Gerontol A. 2017;72:1453-64. Available from: <ext-link ext-link-type="uri" xlink:href="https://academic.oup.com/biomedgerontology/article/3072309/Four">https://academic.oup.com/biomedgerontology/article/3072309/Four</ext-link>.</mixed-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>NT</given-names></name><name><surname>Liestol</surname><given-names>K</given-names></name><name><surname>Loberg</surname><given-names>EM</given-names></name><name><surname>Reims</surname><given-names>HM</given-names></name><name><surname>Brorson</surname><given-names>SH</given-names></name><name><surname>Maehlen</surname><given-names>J</given-names></name></person-group><article-title>The apolipoprotein E polymorphism and cardiovascular diseases--an autopsy study</article-title><source>Cardiovasc Pathol</source><year>2012</year><volume>21</volume><fpage>461</fpage><lpage>469</lpage><pub-id pub-id-type="doi">10.1016/j.carpath.2012.02.005</pub-id><?supplied-pmid 22440829?><pub-id pub-id-type="pmid">22440829</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>C-C</given-names></name><name><surname>Liu</surname><given-names>C-C</given-names></name><name><surname>Kanekiyo</surname><given-names>T</given-names></name><name><surname>Xu</surname><given-names>H</given-names></name><name><surname>Bu</surname><given-names>G</given-names></name></person-group><article-title>Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy</article-title><source>Nat Rev Neurol</source><year>2013</year><volume>9</volume><fpage>106</fpage><lpage>118</lpage><pub-id pub-id-type="doi">10.1038/nrneurol.2012.263</pub-id><?supplied-pmid 23296339?><pub-id pub-id-type="pmid">23296339</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><mixed-citation publication-type="other">Garatachea N, Mar&#x000ed;n PJ, Santos-Lozano A, Sanchis-Gomar F, Emanuele E, Lucia A. The ApoE gene is related with exceptional longevity: a systematic review and meta-analysis. Rejuvenation Res. 2015;18:3&#x02013;13. Available from: <ext-link ext-link-type="uri" xlink:href="http://online.liebertpub.com/doi/abs/10.1089/rej.2014.1605">http://online.liebertpub.com/doi/abs/10.1089/rej.2014.1605</ext-link>, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/25385258">http://www.ncbi.nlm.nih.gov/pubmed/25385258</ext-link>.</mixed-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Willcox</surname><given-names>BJ</given-names></name><name><surname>Donlon</surname><given-names>T a</given-names></name><name><surname>He</surname><given-names>Q</given-names></name><name><surname>Chen</surname><given-names>R</given-names></name><name><surname>Grove</surname><given-names>JS</given-names></name><name><surname>Yano</surname><given-names>K</given-names></name><etal/></person-group><article-title>FOXO3A genotype is strongly associated with human longevity</article-title><source>Proc Natl Acad Sci U S A</source><year>2008</year><volume>105</volume><fpage>13987</fpage><lpage>13992</lpage><pub-id pub-id-type="doi">10.1073/pnas.0801030105</pub-id><?supplied-pmid 18765803?><pub-id pub-id-type="pmid">18765803</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><mixed-citation publication-type="other">Anselmi CV, Malovini A, Roncarati R, Novelli V, Villa F, Condorelli G, et al. Association of the FOXO3A locus with extreme longevity in a southern Italian centenarian study. Rejuvenation Res. 2009;12:95&#x02013;104. Available from: <ext-link ext-link-type="uri" xlink:href="http://online.liebertpub.com/doi/abs/10.1089/rej.2008.0827">http://online.liebertpub.com/doi/abs/10.1089/rej.2008.0827</ext-link>, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/19415983">http://www.ncbi.nlm.nih.gov/pubmed/19415983</ext-link>.</mixed-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>WJ</given-names></name><name><surname>Cao</surname><given-names>H</given-names></name><name><surname>Lu</surname><given-names>J</given-names></name><name><surname>Wu</surname><given-names>C</given-names></name><name><surname>Hu</surname><given-names>FY</given-names></name><etal/></person-group><article-title>Genetic association of FOXO1A and FOXO3A with longevity trait in Han Chinese populations</article-title><source>Hum Mol Genet</source><year>2009</year><volume>18</volume><fpage>4897</fpage><lpage>4904</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddp459</pub-id><?supplied-pmid 19793722?><pub-id pub-id-type="pmid">19793722</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>L</given-names></name><name><surname>Hu</surname><given-names>C</given-names></name><name><surname>Zheng</surname><given-names>C</given-names></name><name><surname>Qian</surname><given-names>Y</given-names></name><name><surname>Liang</surname><given-names>Q</given-names></name><name><surname>Lv</surname><given-names>Z</given-names></name><etal/></person-group><article-title>FOXO3 variants are beneficial for longevity in southern Chinese living in the Red River basin: a case&#x02013;control study and meta-analysis</article-title><source>Sci Rep</source><year>2015</year><volume>5</volume><fpage>9852</fpage><pub-id pub-id-type="doi">10.1038/srep09852</pub-id><?supplied-pmid 25913413?><pub-id pub-id-type="pmid">25913413</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soerensen</surname><given-names>M</given-names></name><name><surname>Dato</surname><given-names>S</given-names></name><name><surname>Christensen</surname><given-names>K</given-names></name><name><surname>McGue</surname><given-names>M</given-names></name><name><surname>Stevnsner</surname><given-names>T</given-names></name><name><surname>Bohr</surname><given-names>VA</given-names></name><etal/></person-group><article-title>Replication of an association of variation in the FOXO3A gene with human longevity using both case&#x02013;control and longitudinal data</article-title><source>Aging Cell</source><year>2010</year><volume>9</volume><fpage>1010</fpage><lpage>1017</lpage><pub-id pub-id-type="doi">10.1111/j.1474-9726.2010.00627.x</pub-id><?supplied-pmid 20849522?><pub-id pub-id-type="pmid">20849522</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flachsbart</surname><given-names>F</given-names></name><name><surname>Caliebe</surname><given-names>A</given-names></name><name><surname>Kleindorp</surname><given-names>R</given-names></name><name><surname>Blanch&#x000e9;</surname><given-names>H</given-names></name><name><surname>von Eller-Eberstein</surname><given-names>H</given-names></name><name><surname>Nikolaus</surname><given-names>S</given-names></name><etal/></person-group><article-title>Association of FOXO3A variation with human longevity confirmed in German centenarians</article-title><source>Proc Natl Acad Sci U S A</source><year>2009</year><volume>106</volume><fpage>2700</fpage><lpage>2705</lpage><pub-id pub-id-type="doi">10.1073/pnas.0809594106</pub-id><?supplied-pmid 19196970?><pub-id pub-id-type="pmid">19196970</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fuku</surname><given-names>N</given-names></name><name><surname>D&#x000ed;az-Pe&#x000f1;a</surname><given-names>R</given-names></name><name><surname>Arai</surname><given-names>Y</given-names></name><name><surname>Abe</surname><given-names>Y</given-names></name><name><surname>Pareja-Galeano</surname><given-names>H</given-names></name><name><surname>Sanchis-Gomar</surname><given-names>F</given-names></name><etal/></person-group><article-title>rs2802292 polymorphism in the FOXO3A gene and exceptional longevity in two ethnically distinct cohorts</article-title><source>Maturitas</source><year>2016</year><volume>92</volume><fpage>110</fpage><lpage>114</lpage><pub-id pub-id-type="doi">10.1016/j.maturitas.2016.07.016</pub-id><?supplied-pmid 27621247?><pub-id pub-id-type="pmid">27621247</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fuku</surname><given-names>N</given-names></name><name><surname>Alis</surname><given-names>R</given-names></name><name><surname>Yvert</surname><given-names>T</given-names></name><name><surname>Zempo</surname><given-names>H</given-names></name><name><surname>Naito</surname><given-names>H</given-names></name><name><surname>Abe</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Muscle-related polymorphisms (mstn rs1805086 and actn3 rs1815739) are not associated with exceptional longevity in Japanese centenarians</article-title><source>PLoS One</source><year>2016</year><volume>11</volume><fpage>e0166605</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0166605</pub-id><?supplied-pmid 27861536?><pub-id pub-id-type="pmid">27861536</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fuku</surname><given-names>N</given-names></name><name><surname>He</surname><given-names>ZH</given-names></name><name><surname>Sanchis-Gomar</surname><given-names>F</given-names></name><name><surname>Pareja-Galeano</surname><given-names>H</given-names></name><name><surname>Tian</surname><given-names>Y</given-names></name><name><surname>Arai</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Exceptional longevity and muscle and fitness related genotypes: a functional in vitro analysis and case&#x02013;control association replication study with SNPs THRH rs7832552, IL6 rs1800795 and ACSL1 rs6552828</article-title><source>Front Aging Neurosci</source><year>2015</year><volume>7</volume><fpage>59</fpage><pub-id pub-id-type="doi">10.3389/fnagi.2015.00059</pub-id><?supplied-pmid 25999849?><pub-id pub-id-type="pmid">25999849</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garatachea</surname><given-names>N</given-names></name><name><surname>Pareja-Galeano</surname><given-names>H</given-names></name><name><surname>Sanchis-Gomar</surname><given-names>F</given-names></name><name><surname>Santos-Lozano</surname><given-names>A</given-names></name><name><surname>Fiuza-Luces</surname><given-names>C</given-names></name><name><surname>Mor&#x000e1;n</surname><given-names>M</given-names></name><etal/></person-group><article-title>Exercise attenuates the major hallmarks of aging</article-title><source>Rejuvenation Res</source><year>2015</year><volume>18</volume><fpage>57</fpage><lpage>89</lpage><pub-id pub-id-type="doi">10.1089/rej.2014.1623</pub-id><?supplied-pmid 25431878?><pub-id pub-id-type="pmid">25431878</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cordell</surname><given-names>HJ</given-names></name></person-group><article-title>Epistasis: what it means, what it doesn&#x02019;t mean, and statistical methods to detect it in humans</article-title><source>Hum Mol Genet</source><year>2002</year><volume>11</volume><fpage>2463</fpage><lpage>2468</lpage><pub-id pub-id-type="doi">10.1093/hmg/11.20.2463</pub-id><?supplied-pmid 12351582?><pub-id pub-id-type="pmid">12351582</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ukraintseva</surname><given-names>S</given-names></name><name><surname>Yashin</surname><given-names>A</given-names></name><name><surname>Arbeev</surname><given-names>K</given-names></name><name><surname>Kulminski</surname><given-names>A</given-names></name><name><surname>Akushevich</surname><given-names>I</given-names></name><name><surname>Wu</surname><given-names>D</given-names></name><etal/></person-group><article-title>Puzzling role of genetic risk factors in human longevity: &#x0201c;risk alleles&#x0201d; as pro-longevity variants</article-title><source>Biogerontology</source><year>2016</year><volume>17</volume><fpage>109</fpage><lpage>127</lpage><pub-id pub-id-type="doi">10.1007/s10522-015-9600-1</pub-id><?supplied-pmid 26306600?><pub-id pub-id-type="pmid">26306600</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niemi</surname><given-names>A-K</given-names></name><name><surname>Moilanen</surname><given-names>JS</given-names></name><name><surname>Tanaka</surname><given-names>M</given-names></name><name><surname>Hervonen</surname><given-names>A</given-names></name><name><surname>Hurme</surname><given-names>M</given-names></name><name><surname>Lehtim&#x000e4;ki</surname><given-names>T</given-names></name><etal/></person-group><article-title>A combination of three common inherited mitochondrial DNA polymorphisms promotes longevity in Finnish and Japanese subjects</article-title><source>Eur J Hum Genet</source><year>2005</year><volume>13</volume><fpage>166</fpage><lpage>170</lpage><pub-id pub-id-type="doi">10.1038/sj.ejhg.5201308</pub-id><?supplied-pmid 15483642?><pub-id pub-id-type="pmid">15483642</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Napolioni</surname><given-names>V</given-names></name><name><surname>Carpi</surname><given-names>FM</given-names></name><name><surname>Giann&#x000ec;</surname><given-names>P</given-names></name><name><surname>Sacco</surname><given-names>R</given-names></name><name><surname>Di Blasio</surname><given-names>L</given-names></name><name><surname>Mignini</surname><given-names>F</given-names></name><etal/></person-group><article-title>Age- and gender-specific epistasis between ADA and TNF-&#x003b1; influences human life-expectancy</article-title><source>Cytokine</source><year>2011</year><volume>56</volume><fpage>481</fpage><lpage>488</lpage><pub-id pub-id-type="doi">10.1016/j.cyto.2011.07.023</pub-id><?supplied-pmid 21865054?><pub-id pub-id-type="pmid">21865054</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>Q</given-names></name><name><surname>Soerensen</surname><given-names>M</given-names></name><name><surname>Kruse</surname><given-names>TA</given-names></name><name><surname>Christensen</surname><given-names>K</given-names></name><name><surname>Christiansen</surname><given-names>L</given-names></name></person-group><article-title>A novel permutation test for case-only analysis identifies epistatic effects on human longevity in the FOXO gene family</article-title><source>Aging Cell</source><year>2013</year><volume>12</volume><fpage>690</fpage><lpage>694</lpage><pub-id pub-id-type="doi">10.1111/acel.12092</pub-id><?supplied-pmid 23607278?><pub-id pub-id-type="pmid">23607278</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jazwinski</surname><given-names>SM</given-names></name><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>Dai</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Bi</surname><given-names>X</given-names></name><name><surname>Jiang</surname><given-names>JC</given-names></name><etal/></person-group><article-title>HRAS1 and LASS1 with APOE are associated with human longevity and healthy aging</article-title><source>Aging Cell</source><year>2010</year><volume>9</volume><fpage>698</fpage><lpage>708</lpage><pub-id pub-id-type="doi">10.1111/j.1474-9726.2010.00600.x</pub-id><?supplied-pmid 20569235?><pub-id pub-id-type="pmid">20569235</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Napolioni</surname><given-names>V</given-names></name><name><surname>Giann&#x000ec;</surname><given-names>P</given-names></name><name><surname>Carpi</surname><given-names>FM</given-names></name><name><surname>Predazzi</surname><given-names>IM</given-names></name><name><surname>Lucarini</surname><given-names>N</given-names></name></person-group><article-title>APOE haplotypes are associated with human longevity in a Central Italy population: evidence for epistasis with HP 1/2 polymorphism</article-title><source>Clin Chim Acta</source><year>2011</year><volume>412</volume><fpage>1821</fpage><lpage>1824</lpage><pub-id pub-id-type="doi">10.1016/j.cca.2011.06.012</pub-id><?supplied-pmid 21703254?><pub-id pub-id-type="pmid">21703254</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santos-Lozano</surname><given-names>A</given-names></name><name><surname>Sanchis-Gomar</surname><given-names>F</given-names></name><name><surname>Pareja-Galeano</surname><given-names>H</given-names></name><name><surname>Fiuza-Luces</surname><given-names>C</given-names></name><name><surname>Emanuele</surname><given-names>E</given-names></name><name><surname>Lucia</surname><given-names>A</given-names></name><etal/></person-group><article-title>Where are supercentenarians located? A worldwide demographic study</article-title><source>Rejuvenation Res</source><year>2015</year><volume>18</volume><fpage>14</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1089/rej.2014.1609</pub-id><?supplied-pmid 25386976?><pub-id pub-id-type="pmid">25386976</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garatachea</surname><given-names>N</given-names></name><name><surname>Emanuele</surname><given-names>E</given-names></name><name><surname>Calero</surname><given-names>M</given-names></name><name><surname>Fuku</surname><given-names>N</given-names></name><name><surname>Arai</surname><given-names>Y</given-names></name><name><surname>Abe</surname><given-names>Y</given-names></name><etal/></person-group><article-title>ApoE gene and exceptional longevity: insights from three independent cohorts</article-title><source>Exp Gerontol</source><year>2014</year><volume>53</volume><fpage>16</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1016/j.exger.2014.02.004</pub-id><?supplied-pmid 24534555?><pub-id pub-id-type="pmid">24534555</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Timmons</surname><given-names>JA</given-names></name><name><surname>Baar</surname><given-names>K</given-names></name><name><surname>Davidsen</surname><given-names>PK</given-names></name><name><surname>Atherton</surname><given-names>PJ</given-names></name></person-group><article-title>Is irisin a human exercise gene?</article-title><source>Nature</source><year>2012</year><volume>488</volume><fpage>E9</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1038/nature11364</pub-id><?supplied-pmid 22932392?><pub-id pub-id-type="pmid">22932392</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bostr&#x000f6;m</surname><given-names>P</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Jedrychowski</surname><given-names>MP</given-names></name><name><surname>Korde</surname><given-names>A</given-names></name><name><surname>Ye</surname><given-names>L</given-names></name><name><surname>Lo</surname><given-names>JC</given-names></name><etal/></person-group><article-title>A PGC1-&#x003b1;-dependent myokine that drives brown-fat-like development of white fat and thermogenesis</article-title><source>Nature</source><year>2012</year><volume>481</volume><fpage>463</fpage><lpage>468</lpage><pub-id pub-id-type="doi">10.1038/nature10777</pub-id><?supplied-pmid 22237023?><pub-id pub-id-type="pmid">22237023</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fiuza-Luces</surname><given-names>C</given-names></name><name><surname>Garatachea</surname><given-names>N</given-names></name><name><surname>Berger</surname><given-names>NA</given-names></name><name><surname>Lucia</surname><given-names>A</given-names></name></person-group><article-title>Exercise is the real Polypill</article-title><source>Physiology</source><year>2013</year><volume>28</volume><fpage>330</fpage><lpage>358</lpage><pub-id pub-id-type="doi">10.1152/physiol.00019.2013</pub-id><?supplied-pmid 23997192?><pub-id pub-id-type="pmid">23997192</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>L&#x000f3;pez-Ot&#x000ed;n</surname><given-names>C</given-names></name><name><surname>Galluzzi</surname><given-names>L</given-names></name><name><surname>Freije</surname><given-names>JMP</given-names></name><name><surname>Madeo</surname><given-names>F</given-names></name><name><surname>Kroemer</surname><given-names>G</given-names></name></person-group><article-title>Metabolic control of longevity</article-title><source>Cell</source><year>2016</year><volume>166</volume><fpage>802</fpage><lpage>821</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.07.031</pub-id><?supplied-pmid 27518560?><pub-id pub-id-type="pmid">27518560</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kenyon</surname><given-names>CJ</given-names></name></person-group><article-title>The genetics of ageing</article-title><source>Nature</source><year>2010</year><volume>464</volume><fpage>504</fpage><lpage>512</lpage><pub-id pub-id-type="doi">10.1038/nature08980</pub-id><?supplied-pmid 20336132?><pub-id pub-id-type="pmid">20336132</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emanuele</surname><given-names>E</given-names></name><name><surname>Minoretti</surname><given-names>P</given-names></name><name><surname>Pareja-Galeano</surname><given-names>H</given-names></name><name><surname>Sanchis-Gomar</surname><given-names>F</given-names></name><name><surname>Garatachea</surname><given-names>N</given-names></name><name><surname>Lucia</surname><given-names>A</given-names></name></person-group><article-title>Serum irisin levels, precocious myocardial infarction, and healthy exceptional longevity</article-title><source>Am J Med</source><year>2014</year><volume>127</volume><fpage>888</fpage><lpage>890</lpage><pub-id pub-id-type="doi">10.1016/j.amjmed.2014.04.025</pub-id><?supplied-pmid 24813865?><pub-id pub-id-type="pmid">24813865</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Staiger</surname><given-names>H</given-names></name><name><surname>B&#x000f6;hm</surname><given-names>A</given-names></name><name><surname>Scheler</surname><given-names>M</given-names></name><name><surname>Berti</surname><given-names>L</given-names></name><name><surname>Machann</surname><given-names>J</given-names></name><name><surname>Schick</surname><given-names>F</given-names></name><etal/></person-group><article-title>Common genetic variation in the human FNDC5 locus, encoding the novel muscle-derived &#x0201c;Browning&#x0201d; factor Irisin, determines insulin sensitivity</article-title><source>PLoS One</source><year>2013</year><volume>8</volume><fpage>e61903</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0061903</pub-id><?supplied-pmid 23637927?><pub-id pub-id-type="pmid">23637927</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barbieri</surname><given-names>M</given-names></name><name><surname>Gambardella</surname><given-names>A</given-names></name><name><surname>Paolisso</surname><given-names>G</given-names></name><name><surname>Varricchio</surname><given-names>M</given-names></name></person-group><article-title>Metabolic aspects of the extreme longevity</article-title><source>Exp Gerontol</source><year>2008</year><volume>43</volume><fpage>74</fpage><lpage>78</lpage><pub-id pub-id-type="doi">10.1016/j.exger.2007.06.003</pub-id><?supplied-pmid 17697759?><pub-id pub-id-type="pmid">17697759</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spiegelman</surname><given-names>BM</given-names></name></person-group><article-title>Banting lecture 2012: regulation of adipogenesis: toward new therapeutics for metabolic disease</article-title><source>Diabetes</source><year>2013</year><volume>62</volume><fpage>1774</fpage><lpage>1782</lpage><pub-id pub-id-type="doi">10.2337/db12-1665</pub-id><?supplied-pmid 23704518?><pub-id pub-id-type="pmid">23704518</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanchis-Gomar</surname><given-names>F</given-names></name><name><surname>Garatachea</surname><given-names>N</given-names></name><name><surname>He</surname><given-names>ZH</given-names></name><name><surname>Pareja-Galeano</surname><given-names>H</given-names></name><name><surname>Fuku</surname><given-names>N</given-names></name><name><surname>Tian</surname><given-names>Y</given-names></name><etal/></person-group><article-title>FNDC5 (irisin) gene and exceptional longevity: a functional replication study with rs16835198 and rs726344 SNPs</article-title><source>Age (Dordr)</source><year>2014</year><volume>36</volume><fpage>9733</fpage><pub-id pub-id-type="doi">10.1007/s11357-014-9733-1</pub-id><pub-id pub-id-type="pmid">25427998</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Craft</surname><given-names>S</given-names></name><name><surname>Asthana</surname><given-names>S</given-names></name><name><surname>Schellenberg</surname><given-names>G</given-names></name><name><surname>Baker</surname><given-names>L</given-names></name><name><surname>Cherrier</surname><given-names>M</given-names></name><name><surname>Boyt</surname><given-names>AA</given-names></name><etal/></person-group><article-title>Insulin effects on glucose metabolism, memory, and plasma amyloid precursor protein in Alzheimer&#x02019;s disease differ according to apolipoprotein-E genotype</article-title><source>Ann N Y Acad Sci</source><year>2000</year><volume>903</volume><fpage>222</fpage><lpage>228</lpage><pub-id pub-id-type="doi">10.1111/j.1749-6632.2000.tb06371.x</pub-id><?supplied-pmid 10818510?><pub-id pub-id-type="pmid">10818510</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aisen</surname><given-names>PS</given-names></name><name><surname>Berg</surname><given-names>JD</given-names></name><name><surname>Craft</surname><given-names>S</given-names></name><name><surname>Peskind</surname><given-names>ER</given-names></name><name><surname>Sano</surname><given-names>M</given-names></name><name><surname>Teri</surname><given-names>L</given-names></name><etal/></person-group><article-title>Steroid-induced elevation of glucose in Alzheimer&#x02019;s disease: relationship to gender, apolipoprotein E genotype and cognition</article-title><source>Psychoneuroendocrinology</source><year>2003</year><volume>28</volume><fpage>113</fpage><lpage>120</lpage><pub-id pub-id-type="doi">10.1016/S0306-4530(02)00015-X</pub-id><?supplied-pmid 12445840?><pub-id pub-id-type="pmid">12445840</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>SJ</given-names></name></person-group><article-title>Methodological problems in genetic association studies of longevity--the apolipoprotein E gene as an example</article-title><source>Int J Epidemiol</source><year>2004</year><volume>33</volume><fpage>962</fpage><lpage>970</lpage><pub-id pub-id-type="doi">10.1093/ije/dyh214</pub-id><?supplied-pmid 15319409?><pub-id pub-id-type="pmid">15319409</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Passarino</surname><given-names>G</given-names></name><name><surname>Montesanto</surname><given-names>A</given-names></name><name><surname>Dato</surname><given-names>S</given-names></name><name><surname>Giordano</surname><given-names>S</given-names></name><name><surname>Domma</surname><given-names>F</given-names></name><name><surname>Mari</surname><given-names>V</given-names></name><etal/></person-group><article-title>Sex and age specificity of susceptibility genes modulating survival at old age</article-title><source>Hum Hered</source><year>2006</year><volume>62</volume><fpage>213</fpage><lpage>220</lpage><pub-id pub-id-type="doi">10.1159/000097305</pub-id><?supplied-pmid 17124418?><pub-id pub-id-type="pmid">17124418</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yashin</surname><given-names>AI</given-names></name><name><surname>De Benedictis</surname><given-names>G</given-names></name><name><surname>Vaupel</surname><given-names>JW</given-names></name><name><surname>Tan</surname><given-names>Q</given-names></name><name><surname>Andreev</surname><given-names>KF</given-names></name><name><surname>Iachine</surname><given-names>IA</given-names></name><etal/></person-group><article-title>Genes, demography, and life span: the contribution of demographic data in genetic studies on aging and longevity</article-title><source>Am J Hum Genet</source><year>1999</year><volume>65</volume><fpage>1178</fpage><lpage>1193</lpage><pub-id pub-id-type="doi">10.1086/302572</pub-id><?supplied-pmid 10486337?><pub-id pub-id-type="pmid">10486337</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dato</surname><given-names>S</given-names></name><name><surname>Carotenuto</surname><given-names>L</given-names></name><name><surname>Benedictis</surname><given-names>G</given-names></name></person-group><article-title>Genes and longevity: a genetic-demographic approach reveals sex- and age-specific gene effects not shown by the case&#x02013;control approach (APOE and HSP70.1 loci)</article-title><source>Biogerontology</source><year>2007</year><volume>8</volume><fpage>31</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1007/s10522-006-9030-1</pub-id><?supplied-pmid 16896546?><pub-id pub-id-type="pmid">16896546</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murakami</surname><given-names>H</given-names></name><name><surname>Iemitsu</surname><given-names>M</given-names></name><name><surname>Fuku</surname><given-names>N</given-names></name><name><surname>Sanada</surname><given-names>K</given-names></name><name><surname>Gando</surname><given-names>Y</given-names></name><name><surname>Kawakami</surname><given-names>R</given-names></name><etal/></person-group><article-title>The Q223R polymorphism in the leptin receptor associates with objectively measured light physical activity in free-living Japanese</article-title><source>Physiol Behav</source><year>2014</year><volume>129</volume><fpage>199</fpage><lpage>204</lpage><pub-id pub-id-type="doi">10.1016/j.physbeh.2014.02.053</pub-id><?supplied-pmid 24631298?><pub-id pub-id-type="pmid">24631298</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gondo</surname><given-names>Y</given-names></name><name><surname>Hirose</surname><given-names>N</given-names></name><name><surname>Arai</surname><given-names>Y</given-names></name><name><surname>Inagaki</surname><given-names>H</given-names></name><name><surname>Masui</surname><given-names>Y</given-names></name><name><surname>Yamamura</surname><given-names>K</given-names></name><etal/></person-group><article-title>Functional status of centenarians in Tokyo, Japan: developing better phenotypes of exceptional longevity</article-title><source>J Gerontol A Biol Sci Med Sci</source><year>2006</year><volume>61</volume><fpage>305</fpage><lpage>310</lpage><pub-id pub-id-type="doi">10.1093/gerona/61.3.305</pub-id><?supplied-pmid 16567382?><pub-id pub-id-type="pmid">16567382</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Purcell</surname><given-names>S</given-names></name><name><surname>Neale</surname><given-names>B</given-names></name><name><surname>Todd-Brown</surname><given-names>K</given-names></name><name><surname>Thomas</surname><given-names>L</given-names></name><name><surname>Ferreira</surname><given-names>MAR</given-names></name><name><surname>Bender</surname><given-names>D</given-names></name><etal/></person-group><article-title>PLINK: a tool set for whole-genome association and population-based linkage analyses</article-title><source>Am J Hum Genet</source><year>2007</year><volume>81</volume><fpage>559</fpage><lpage>575</lpage><pub-id pub-id-type="doi">10.1086/519795</pub-id><?supplied-pmid 17701901?><pub-id pub-id-type="pmid">17701901</pub-id></element-citation></ref></ref-list></back></article>